Stock Market News for June 26, 2026
301 news published.
Regulatory and approval milestones reshaping oncology, ophthalmology and immunology plays
Datroway (AZN) kept momentum as the CHMP recommended EU approval for use as a first‑line treatment in metastatic triple‑negative breast cancer, widening potential uptake in a hard‑to‑treat segment.
Eli Lilly (LLY) scored a major regulatory win as the CHMP recommended Jaypirca (pirtobrutinib) for EU approval across all lines in CLL, a development that may alter BTK inhibitor market dynamics.
Lantheus (LNTH) received a Complete Response Letter from the FDA for LNTH‑2501, delaying a nuclear‑diagnostics label expansion and creating a near‑term commercial headwind.
Replimune (REPL) announced FDA acceptance of its RP1 BLA resubmission for advanced melanoma, starting a review clock and reducing regulatory uncertainty for its oncolytic candidate.
AbbVie (ABBV) received FDA approval to use SKYRIZI® (risankizumab‑rzaa) in pediatric psoriatic disease, a label expansion that broadens the drug’s addressable market and recurring biologic revenue streams.
Viridian Therapeutics (VRDN) announced U.S. FDA approval and launch of Lumvoa™ (veligrotug‑vvze) for thyroid eye disease, moving the biotech into a commercial stage with near‑term revenue potential and investor focus on uptake and pricing.
Clinical data, trials and scientific validation
Axsome Therapeutics (AXSM) initiated the FOCUS‑3 Phase 3 trial of solriamfetol in adolescents with ADHD — a successful readout could meaningfully expand label and revenue runway.
Monopar (MNPR) presented new analyses from its Phase 3 FoCus study at EAN 2026 showing greater neurologic and global clinical benefit with ALXN1840 versus standard of care in Wilson disease, strengthening the commercial and reimbursement case in a rare‑disease niche.
Index inclusions, rebalances and passive‑flow drivers
Ascendis Pharma (ASND) is joining multiple Russell U.S. indexes — including the Russell 3000®, 1000®, 2500® and Midcap® — a classic passive‑demand trigger that can boost near‑term volume.
Nasdaq (NDAQ) reported record trading volume on the Nasdaq Closing Cross during the June Russell reconstitution, underscoring liquidity compression and amplified price moves for names near the cut.
dLocal (DLO) was added to the US small‑cap Russell 2000® Index, a change likely to attract passive flows and affect short‑term demand for the stock.
M&A, corporate transactions and shareholder votes
The Doctors Company (PRA) completed the acquisition of ProAssurance, creating scale in specialty insurance; investors will model synergy timing into forward earnings.
Kite Realty Group (KRG) closed the sale of City Center, strengthening the balance sheet and optionality for redevelopment or shareholder returns.
Select Medical Holdings (SEM) received stockholder approval for an acquisition by a consortium led by Robert Ortenzio, Martin Jackson and WCAS, a transaction that takes the company private and shifts valuation lenses for investors.
Quarterly outlooks and operating updates traders will parse
GameStop (GME) provided a fiscal 2026 outlook, offering guidance that investors will weigh against turnaround progress and working‑capital dynamics in retail and digital initiatives.
International Paper (IP) announced a continued strategic transformation and North America packaging network optimization, moves aimed at margin expansion and capital efficiency that bear on medium‑term earnings power.
Energy, utilities and infrastructure moves affecting rates and reliability
Ameren (AEE) filed to update electric rates in mid‑2027, citing storm hardening, grid upgrades and new generation; the docket matters for regulated earnings and capex recovery timelines.
Capital raises, delistings and market access
TEN Holdings (XHLD) priced a $7.5 million offering, a financing that will be modeled into near‑term capitalization and runway assumptions for the smaller issuer.
TNL Mediagene (TNMG) received a Nasdaq delisting determination and plans to request a hearing — a binary governance event that can materially affect liquidity and investor claims.
The LGL Group (LGL) announced rights trading on the OTC Markets under "LGLGR", a technical change relevant to holders and secondary market access during its subscription process.
Mining, resources and strategic cooperation
Tianci International (CIIT) and Greypole Mining provided an update on strategic cooperation in Zimbabwe for gold and chromium resource development, a regional consolidation that can accelerate permitting and project economics if followed by capital commitments.
Defense and large‑contract awards
RTX’s Raytheon secured a $1.1 billion U.S. Navy contract for AIM‑9X Block II missiles, adding near‑term backlog visibility for primes and key suppliers in the supply chain.
Technology, AI infrastructure and campus expansion
Hyperscale Data (GPUS) completed acquisition of 48.5 acres to expand its Michigan AI data‑center campus, signaling sustained demand for generative AI compute capacity.
VEON (VEON) said Kyivstar signed an MoU with Ukraine’s Ministry of Economy to accelerate AI infrastructure and digital growth, highlighting telecoms' strategic role in national tech plans.
Smaller tactical items retained for market impact
Blue Moon Metals (BMM) and Alpha Future Funds signed a binding agreement to combine holdings in Norway’s Sulitjelma mining district, a consolidation that can speed permitting and exploration scale.
Uranium Royalty Corp. (UROY) filed its management information circular related to a proposed arrangement with Sweetwater Investors, with exchangeable share elections and vote timing that affect capital structure exposure.
Universe Pharmaceuticals (UPC) announced a strategic acquisition to expand its patent portfolio, a move to broaden product shelf and licensing leverage.
New, high‑impact items will be woven into these sections as they arrive; lower‑impact notices are shortened or removed to keep this update focused on developments that can change valuations, liquidity or the market outlook for investors.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement